XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Net Income (Loss) Per Class A Common Share
3 Months Ended
Mar. 31, 2023
Net Income (Loss) Per Class A Common Share  
Net Income (Loss) Per Class A Common Share

​

Note 9  Net Income (Loss) Per Class A Common Share

Basic income (loss) per share is computed by dividing net income (loss) attributable to Enfusion, Inc. by the weighted-average number of shares of Class A common stock outstanding during the period. Diluted loss per share is computed giving effect to all potentially dilutive shares.

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income (loss) per share of Class A common stock is as follows:

​

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 

(in thousands, except per share amounts)

    

2023

    

2022

Net income (loss)

​

$

4,694

​

$

(12,524)

Less: Net (income) loss attributable to non-controlling interests

​

​

(1,749)

​

​

5,259

Net income (loss) attributable to Enfusion, Inc.

​

$

2,945

​

$

(7,265)

Numerator:

​

​

​

​

​

​

Net income (loss) attributable to Enfusion, Inc.

​

$

2,945

​

$

(7,265)

Adjustment to income (loss) attributable to common stockholders

​

​

226

​

​

(716)

Numerator for Basic Earnings per Share

​

$

3,171

​

$

(7,981)

Adjustment to Income for Dilutive Shares

​

​

1,523

​

​

-

Numerator for Diluted Earnings per Share

​

$

4,694

​

$

(7,981)

Denominator:

​

​

​

​

​

​

Weighted-average shares of Class A common stock outstanding

​

​

72,272

​

​

65,583

Vested shares of Class A common stock and RSUs

​

​

16,591

​

​

17,801

Weighted-average shares of Class A common stock outstanding--basic

​

​

88,863

​

​

83,384

Add: Dilutive Shares

​

​

43,483

​

​

-

Weighted-average shares of Class A common stock outstanding--diluted

​

​

132,346

​

​

83,384

Net income (loss) per share of Class A common stock--Basic

​

$

0.04

​

$

(0.10)

Net income (loss) per share of Class A common stock--Diluted

​

$

0.04

​

$

(0.10)

​

The following number of potentially dilutive shares were excluded from the calculation of diluted income (loss) per share because the effect of including such potentially dilutive shares would have been antidilutive:

​

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 

(in thousands)

    

2023

    

2022

Class B common stock

​

    

-

​

    

47,471

Contingently issuable shares of Class A common stock

​

​

-

​

​

893

Restricted stock units

​

​

110

​

​

2,857

Stock options

​

​

84

​

​

-

​

​

​

194

​

​

51,221

​

Shares of Class B common stock do not share in earnings and are not participating securities. Accordingly, separate presentation of loss per share of Class B common stock under the two-class method has not been presented. Shares of Class B common stock are, however, considered potentially dilutive shares of Class A common stock. After evaluating the potential dilutive effect under both the treasury stock method and if-converted method, shares of Class B common stock were determined to be dilutive for the three months ended March 31, 2023, and have therefore been included in the computation of diluted earnings per share of Class A common stock. However, for the three months ended March 31, 2022, shares of Class B common stock were determined to be anti-dilutive, and have therefore been excluded from the computation of diluted earnings per share of Class A common stock.